Timing of Smoking Intervention in Alcohol Treatment (Nicotine Patch)
NCT ID: NCT00000444
Last Updated: 2011-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
500 participants
INTERVENTIONAL
1997-09-30
2004-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Combination Nicotine Replacement for Alcoholic Smokers
NCT00064844
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
NCT00000437
Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
NCT00699556
Effectiveness of Various Smoking Cessation Therapies in Reducing Smoking in Adolescents - 1
NCT00158171
Varenicline and Alcohol in Inpatient Addictions Program (IAP)
NCT01169610
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
nicotine replacement patch
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Complete first week of alcohol treatment program.
* Current cigarette smoker (more than 5 cigarettes/day, smoking more than 1 year).
Exclusion Criteria
* Unable to participate in protocol due to functional deficits or severe depression.
* Suicidal or homicidal ideation.
* Current use of disulfiram (Antabuse) or naltrexone (Revia).
* Current use of pipes, cigars, or smokeless tobacco and unwillingness to stop.
* Lives more than 100 miles from alcohol treatment facility.
* No telephone.
21 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
NIH
Minneapolis Veterans Affairs Medical Center
FED
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Internal Medicine, VA Medical Center
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIAAAJOS11124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.